
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
Science Corporation completed its first implant of a vision-restoring chip in a patient with Stargardt disease, marking progress in retinal implant technology. The procedure represents advancement in brain-computer interfaces, with involvement from Max Hodak, former Neuralink co-founder.




























